drugset / Trial / NCT00809471

Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D)

NCT00809471

Phase 3 Completed 390 enrolled VIVUS LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is being conducted to compare the safety and efficacy of 2 doses of avanafil to placebo in diabetic men with mild to severe erectile dysfunction.

Timeline

Start
2008-12
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Avanafil Small molecule 100 mg Oral
Subject Avanafil Small molecule 200 mg Oral

Indications